SEAL @556 (50.0%) on 22-apr-2012 [ 1 ] using (humira, abbott_laboratories)
CPL @1095 (87.5%) on 17-jan-2018 [ "arg2 Laboratories as arg1" "arg2 received FDA approval for arg1" "arg2 Laboratories announced that arg1" ] using (humira, abbott)
SEAL @263 (75.0%) on 22-may-2011 [ 12 ] using (humira, abbott)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 marketed by arg2" ] using (humira, abbott_laboratories)
SEAL @556 (87.5%) on 22-apr-2012 [ 123 ] using (kaletra, abbott_laboratories)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 discovered and developed arg1" "arg2 under the brand names arg1" ] using (kaletra, abbott)
CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 sells as arg1" "arg2 holds the patent for arg1" "arg2 under the trade name arg1" "arg2 sells under the brand name arg1" ] using (kaletra, abbott_laboratories)
SEAL @241 (75.0%) on 22-apr-2011 [ 12 ] using (kaletra, abbott)
CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 to voluntarily remove arg1" "arg2 under the brand name arg1" "arg2 under the brand names arg1" "arg2 voluntarily withdrew arg1" "arg2 appetite suppressant arg1" ] using (meridia, abbott_laboratories)
CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 It is manufactured by arg2" "arg1 is marketed by arg2" "arg1 is manufactured by arg2" ] using (norvir, abbott_laboratories)
CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 holds a patent on arg1" "arg2 Laboratories under the brand name arg1" ] using (norvir, abbott)
SEAL @526 (87.5%) on 07-mar-2012 [ 123 ] using (norvir, abbott_laboratories)
SEAL @241 (87.5%) on 22-apr-2011 [ 123 ] using (norvir, abbott)
CPL @1095 (75.0%) on 17-jan-2018 [ "arg1 is a registered Trademark of arg2" "arg1 is a registered trademark of arg2" ] using (meridia, abbott_laboratories)
CPL @1095 (75.0%) on 17-jan-2018 [ "arg1 is a registered Trademark of arg2" "arg1 is a registered trademark of arg2" ] using (abbott_laboratories, meridia)